Showing results (31-40 of 113) with videos related to
Sort By:
Pageof 12
ACS Chemical Neuroscience|January 11, 2021
Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's DiseaseMarta Campora, Claudio Canale, Elena Gatta, et al.European Journal of Medicinal Chemistry|October 27, 2018
Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitorsLeonardo Pisani, Rosa Maria Iacobazzi, Marco Catto, et al.Molecules (Basel, Switzerland)|November 11, 2022
<i>N</i>-Hydroxy-<i>N</i>-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine OxidasesÓscar M Bautista-Aguilera, José M Alonso, Marco Catto, et al.Molecules (Basel, Switzerland)|February 15, 2022
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE)Rosalba Leuci, Leonardo Brunetti, Antonio Laghezza, et al.Molecules (Basel, Switzerland)|July 9, 2022
Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and CholinesterasesRosa Purgatorio, Nicola Gambacorta, Francesco Samarelli, et al.European Journal of Medicinal Chemistry|September 2, 2017
Novel chemotypes targeting tubulin at the colchicine binding site and unbiasing P-glycoproteinGiuseppe Felice Mangiatordi, Daniela Trisciuzzi, Domenico Alberga, et al.Frontiers in Chemistry|October 27, 2022
A twenty-year journey exploring coumarin-based derivatives as bioactive moleculesLeonardo Pisani, Marco Catto, Giovanni Muncipinto, et al.Molecules (Basel, Switzerland)|September 10, 2021
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer DiseaseRosa Purgatorio, Nicola Gambacorta, Modesto de Candia, et al.Journal of Medicinal Chemistry|August 4, 2006
Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approachesMarco Catto, Orazio Nicolotti, Francesco Leonetti, et al.ACS Chemical Neuroscience|January 9, 2026
Assessing the Multitarget Therapeutic Potential of Novel 9-Aminoacridine Derivatives for Alzheimer's DiseaseValeria Francesconi, Anna Carbone, Gabriella La Spada, et al.Pageof 12